NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 138 filers reported holding NEOGENOMICS INC in Q3 2016. The put-call ratio across all filers is 0.25 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,339,927 | -4.4% | 596,742 | +25.0% | 0.08% | 0.0% |
Q2 2023 | $7,674,228 | -2.2% | 477,550 | +6.0% | 0.08% | -5.1% |
Q1 2023 | $7,844,076 | +77.8% | 450,550 | -5.7% | 0.08% | +71.7% |
Q4 2022 | $4,412,562 | -33.2% | 477,550 | -37.7% | 0.05% | -38.7% |
Q3 2022 | $6,602,000 | +35.8% | 766,750 | +28.6% | 0.08% | +50.0% |
Q2 2022 | $4,861,000 | +8.1% | 596,450 | +61.2% | 0.05% | +31.6% |
Q1 2022 | $4,496,000 | +102.7% | 370,000 | +469.2% | 0.04% | +123.5% |
Q4 2021 | $2,218,000 | -29.3% | 65,000 | 0.0% | 0.02% | -26.1% |
Q3 2021 | $3,136,000 | -7.4% | 65,000 | -13.3% | 0.02% | 0.0% |
Q2 2021 | $3,388,000 | -6.3% | 75,000 | 0.0% | 0.02% | -4.2% |
Q1 2021 | $3,617,000 | -61.8% | 75,000 | -57.3% | 0.02% | -69.2% |
Q4 2020 | $9,459,000 | +45.9% | 175,683 | 0.0% | 0.08% | +11.4% |
Q3 2020 | $6,481,000 | +10.6% | 175,683 | -7.1% | 0.07% | +7.7% |
Q2 2020 | $5,861,000 | -5.1% | 189,183 | -15.4% | 0.06% | -22.6% |
Q1 2020 | $6,176,000 | -18.9% | 223,683 | -14.1% | 0.08% | +23.5% |
Q4 2019 | $7,619,000 | +40.3% | 260,483 | -8.3% | 0.07% | +36.0% |
Q3 2019 | $5,432,000 | -48.3% | 284,103 | -40.7% | 0.05% | -47.4% |
Q2 2019 | $10,503,000 | +5.4% | 478,703 | -1.7% | 0.10% | +13.1% |
Q1 2019 | $9,968,000 | +69.2% | 487,203 | +4.3% | 0.08% | +58.5% |
Q4 2018 | $5,891,000 | +18.2% | 467,203 | +43.9% | 0.05% | +55.9% |
Q3 2018 | $4,984,000 | +13.8% | 324,700 | -2.8% | 0.03% | +13.3% |
Q2 2018 | $4,379,000 | +60.7% | 334,000 | 0.0% | 0.03% | +57.9% |
Q1 2018 | $2,725,000 | -65.7% | 334,000 | -62.7% | 0.02% | -64.2% |
Q4 2017 | $7,938,000 | -25.4% | 895,900 | -6.3% | 0.05% | -25.4% |
Q3 2017 | $10,639,000 | +24.2% | 955,900 | 0.0% | 0.07% | +24.6% |
Q2 2017 | $8,565,000 | +78.8% | 955,900 | +57.5% | 0.06% | +83.9% |
Q1 2017 | $4,789,000 | -7.5% | 607,000 | +0.5% | 0.03% | -6.1% |
Q4 2016 | $5,176,000 | -3.7% | 604,000 | -7.6% | 0.03% | -5.7% |
Q3 2016 | $5,376,000 | +2.2% | 654,000 | 0.0% | 0.04% | 0.0% |
Q2 2016 | $5,258,000 | +64.9% | 654,000 | +38.3% | 0.04% | +75.0% |
Q1 2016 | $3,188,000 | +224.0% | 473,000 | +278.4% | 0.02% | +233.3% |
Q4 2015 | $984,000 | – | 125,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |